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Abstract
We describe a method to identify metabolites of proteins that eliminates endogenous background by using stable
isotope labeled matrices. This technique allows selective screening of the intact therapeutic molecule and all
metabolites using a modified precursor ion scan that monitors low molecular weight fragment ions produced
during MS/MS. This distinct set of low mass ions differs between isotopically labeled and natural isotope
containing species allowing excellent discrimination between endogenous compounds and target analytes. All
compounds containing amino acids that consist of naturally abundant isotopes can be selected using this
scanning technique for further analysis, including metabolites of the parent molecule. The sensitivity and selectivity
of this technique is discussed with specific examples of insulin metabolites identified within a complex matrix
using a range of different validated low mass target ions.
Background
Mass spectrometry (MS) can identify molecules based
on their distinctive mass and/or on the mass of product
ions generated by fragmentation of the parent ion. It is
this sensitivity and selectivity that is often exploited to
distinguish a target peptide from a mixture of other clo-
sely related species [1]. The common approach for pep-
tide identification is to use characteristic fragment ions
produced during relatively mild collision activated disso-
ciation of parent ions. The series of “sequencing” ions
produced differ in mass by the residue mass of specific
amino acids in addition to various neutral losses and
intramolecular reactions. These ions then enable the de
novo reconstruction of the primary structure of the par-
ent peptide ion from the spectrum of fragment ions.
This systematic approach relies on the prediction the
fragmentation pattern of the peptide, however many
variables such as collision energy and sequence compo-
sition influence fragmentation, often making it difficult
to predict ion intensity relationships. This can then lead
to challenges in the interpretation and prediction of
MS/MS spectrum [2-5]. The uncertainty in how a
particular peptide may fragment and the reliance of a
classical “sequencing ions” approach to peptide identifi-
cation may in some cases lead to the incomplete assign-
ment of the spectra, where sequencing ions provide an
internal sequence “tag” but fail to provide enough infor-
mation for a complete peptide sequence. This is espe-
cially the case when the data from which peptide
identities are made is of poor quality due to very low
abundance of the parent species, or if there is only a
small number of MS/MS ions present that can be used
for sequencing. These sequencing difficulties are further
compounded when attempting to identify peptides in
very complex samples.
We propose that stable isotope labelling can improve
the certainty of peptide identity. Stable isotope labelling
amino acids in cell culture (SILAC), where the “heavy”
isotope (
13C,
15N etc.) is used for quantification of pro-
teins by MS, is now a well-established, safe and repro-
ducible technique [6]. The advantage of SILAC is that
the only chemical difference is a single neutron that
alters the atom and subsequently the amino acid mass,
while not altering its biological relevance. There have
also been significant advances in the complete incor-
poration of stable isotopes into multicellular organisms
such as mice, with heavy isotope mouse feed now com-
mercially available [6,7]. Thus the scope of experiments
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range from simple experiments in prokaryotes through
to complex experiments in genetically modified mice. In
this study we demonstrate how stable isotope labelling
can be used for the discovery and identification of pep-
tide metabolites. In contrast to similar studies where the
protein or biotherapeutic is modified by incorporation
of a stable isotope [8,9], we propose the inverse, where
the entire matrix is modified instead of the target pro-
tein. Complete incorporation of, in our case,
15Ni n t o
the matrix of interest allows discrimination between
matrix-derived metabolites and peptides derived from
the target protein.
In addition to validating peptide identity, differential
labeling can be combined with triple quadrupole tech-
nology to enable targeted data acquisition, whether in
the form of multiple reaction monitoring (MRM) or
during precursor ion scanning. The former technique is
extremely sensitive and is currently being exploited for
quantitation of known compounds; however, MRM
requires knowledge of the precursor mass of the analyte
which in the case of metabolites is often unknown. In
contrast, precursor ion scanning can be performed with-
out prior knowledge of the precursor mass. Combining
this with the knowledge of a specific and distinguishing
fragment ion can enable the use of “information depen-
dant acquisition” (IDA) to reveal the full MS/MS of tar-
get compounds. We describe how, by using a stable
isotope labeled matrix, we are able to employ the pre-
cursor ion scan to detect molecules liberated from insu-
lin. Here the shifted matrix results in the otherwise
“normal” fragment ions of the insulin becoming the
unique and distinguishing features that can be harnessed
to trigger targeted MS/MS analysis.
The target ions used in this case are low mass ions
that are below 200 m/z; these ions include, but are not
limited to, the immonium and related ions and can be
indicators for the presence of corresponding unlabeled
amino acid residues (Table 1). Currently low mass ions
are under-exploited in peptide identification; however,
recent studies such as Hohmann et al [10] suggest that
the immonium ion can be used as a quantitative indica-
tor. The presence and relative intensity of the immo-
nium ion reflect not only the presence of a particular
amino acid residue but can also describe where within
the peptide the residue is located. In our study we are
particularly interested in the immonium ion due to its
relationship to peptide amino acid composition. The
immonium ion can form through various context-
dependant mechanisms but consists of the general
structure RCH = NH2
+ with R being the side chain of
the amino acid residue. This results in a defined set of
immonium ions (and related ions that have undergone
an additional fragmentation in the form of a neutral
loss) that represent all of the 20 common amino acids.
The particular feature of these ions that has been
exploited in this study is that the immonium ions always
contain at least one nitrogen as a remnant from the
amide bond found in all peptides. This has meant that
with the complete incorporation of
15N in a metabolic
matrix, the immonium ions derived from endogenous
peptides found within the matrix will not be observable
at the normal m/z.
During this study we tested the ability to selectively
screen out specific peptides from a
15N complex mixture
using immonium ions corresponding to amino acid resi-
dues found within a target peptide. Figure 1 shows the
well characterized Glu Fibrinopeptide EGVNDNEEGFF-
SAR (GluFib) being selectively screened from a complex
mixture. Here 1 pmol of GluFib is added to a complex
matrix consisting of 40 μg
15N compounds taken from
the acid soluble fraction of E. coli which had been cul-
tured exlusively in
15N media. A multiple precursor ion
scan that simultaneously monitors for more than one
target ion (in this case two) is employed to target the
MS analysis towards GluFib. The target ions used are 72
and 120 and represent the amino acid residues of valine
and phenylalanine respectively. During this analysis the
entire matrix was ignored and signal detection from the
precursor scan was only obtained from unlabeled Glu-
Fib, thus triggering a targeted MS/MS While at 1 pmol
concentration it is possible to identify GluFib within this
matrix using a conventional LC-MS/MS approach, the
differential isotope labeling enables high confidence dur-
ing characterization with conventional sequencing. In
addition, only MS/MS spectra belonging to GluFib is
provided, reducing the data load for search algorithms.
The real advantage of this strategy is in situations
where target molecules coelute with many compounds
of higher intensity. We therefore directly compared the
targeted precursor scan data acquisition to untargeted
LC-MS/MS where GluFib was titrated into a
15Nc o m -
plex mixture (40 μg
15N as above). In Figure 2 (i, A-C))
we show the total ion chromatogram (TIC) of all three
product ion spectra acquired as a result of IDA during a
single LC-MS/MS when 50 fmol of GluFib is added to
the complex mixture. At this concentration GluFib is
completely ignored and not selected for product ion
acquisition during untargeted LC-MS/MS. In contrast,
when the same sample was run with identical LC and
ion source conditions, but with a precursor ion scan
monitoring for an immonium ion for valine (72 m/z),
GluFib was efficiently detected. The TIC for the precur-
sor scan in Figure 2 (ii, D-F) shows a strong and distinct
signal when GluFib is present despite the enhanced
mass spectrum (EMS) that was obtained during IDA
showing low abundance of the target ion (785.7 amu,
Figure 2F), relative to all other ions present. During this
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Residue Native Immonium ion Related native ions
15N Immonium ion
Alanine, A 44 45
Arginine, R 129 59,70,73,87,100, 112 133
Asparagine, N 87 70 89
Apartic acid, D 88 70 89
Cysteine, C 76 77
Glutamic acid, E 102 103
Glutamine, Q 101 56,84,129 103
Glycine, G 30 31
Histidine, H 110 82,121,123, 138,166 113
Isoleucine, I 86 44,72 87
Phenylalanine, F 120 91 121
Proline, P 70 71
Leucine, L 86 44,72 87
Lysine, K 101 70,84,112,129 103
Methionine, M 104 61,70 105
Serine, S 60 61
Threonine, T 74 75
Tryptophan, W 159 77,117,130,132, 170,171 161
Tyrosine, Y 136 91, 107 137
Valine, V 72 41,55,69 73
Insulin tryptic peptides Target ions used for precursor scanning
FVNQHLCGSHLVEALYLVCGER 120 (F), 70 (P/R/N), 86 (L/I), 72 (V)
GFFYTPKT 120 (F), 70 (P/R/N)
GIVDQCCTSICSLYQLENYCN 72 (V), 86 (L/I), 70 (P/R/N)
(Top) List of immonium and related ions for the 20 naturally abundant amino acids and the expected isotopic shifts of immonium ions when 15N labeled.
(Bottom) Tryptic Insulin digest peptides and the potential target ions to be used for information dependant MS/MS acquisition (IDA) targets during a precursor
ion scan.
Figure 1 Multiple precursor ion scanning for GluFib from within a complex mixture.1p m o lo fG l u F i bw a sa d d e dt o4 0μg
15Nm a t r i x
consisting of the acid soluble fraction of E. coli. A double precursor ion scan was performed using the immonium ion targets of (A) 72 (valine)
and (C) 120 (phenylalanine). Figure 1, shows the precursor ion scans both detect the 786 m/z ion (B and D respectively) and subsequently
trigger IDA of a product ion spectra (E) that produces sequencing ions for the GluFib peptide EGVNDNEEGFFSAR.
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Page 3 of 7Figure 2 Precursor ion scanning for GluFib from a
15N complex mixture below the detection level of a traditional LC-MS/MS approach.
100 fmol of GluFib was spiked into 80 μg (total protein) of a
15N matrix consisting of the acid soluble fraction of E. coli and split into two. One
half was analysed as a regular LC-MS/MS (i) while the other as a Precursor scan for m/z 72 valine (ii). At this concentration of GluFib the regular
LC-MS/MS did not select the target peptide for MS/MS due to the complexity of the sample. In contrast the precursor scan identified GluFib and
automatically selected it for MS/MS data acquisition. The LC-MS/MS experiment consisted of an IDA that selects the three most intense ions
from each mass spectrum for product ion acquisition. (i) Shows the TIC of all three product ion spectra acquired during the single LC-MS/MS
experiment, none of which selected the precursor mass of 786 m/z (GluFib) for product ion acquisition due to the complexity of the sample. In
contrast the precursor scan (ii) shows the product ion spectra TIC (E) with a peak at 33.5 mins, the precursor ion triggering IDA at this time point
had an m/z 786, corresponding to GluFib and appropriately product ion spectra was acquired for confirmation. (F) The total mass spectrum
corresponding to the time point when GluFib was detected and triggered product ion data acquisition, highlighting the low abundance of the
GluFib m/z 786 ion relative to the complex background. (D) Extracted ion chromatogram (XIC) for the GluFib precursor mass from the precursor
scan for m/z 72 showing the most intense signal during the elution of GluFib. (The precursor ion scan chromatograms are cropped to highlight
the time when GluFib is eluted.)
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spectra acquired until the time point 33.4 min, which is
consistent with the highest concentration of GluFib dur-
ing the chromatographic elution when an extracted ion
chromatogram is performed on the precursor ion scan
(Figure 2D).
Furthermore, the selection of the internal residues
valine and phenylalanine illustrates the strength of the
approach through its ability to employ a variety of low
mass ions that can come from residues found through-
out the target peptide.
Lastly this targeted approach to metabolite identifica-
tion is especially relevant to the monitoring and discov-
ery of biotherapeutic metabolites in complex matrices
where targets are of unknown precursor mass. Here we
took peptides derived from a tryptic digest of injectable
insulin and added them to the same complex matrix
mentioned above (40 μg
15N as above). We observed
specificity and selectivity for peptides liberated from
insulin by virtue of proteolysis by bacterial peptidases
contained within the E. Coli lysate. The same sample
was also run as a standard LC-MS/MS experiment and
both results submitted to a ProteinPilot version 4 search
algorithm. While the LC-MS/MS came back with no
positive identifications for insulin, the precursor scan
identified the predicted tryptic peptides as well as addi-
tional unexpected insulin peptides. These included pep-
tides with modified cysteine residues and truncated
peptides that were the result of residual protease activity
within the
15N E. coli matrix.
The experimental cycle loop of the 4000 QTrap
instrument used consisted of precursor ion scans that
targeted up to four specific immonium ions, with
the detection of any one of these ions prompting IDA.
Figure 3 Insulin peptides were combined with a
15N complex matrix. 2 pmol of an insulin tryptic digest was added to 40 μg (total protein)
of a
15N matrix, consisting of the acid soluble fraction of E. coli. The same sample was run as a regular LC-MSMS experiment and as precursor
ion scanning experiments. Target ions during the precursor scans consisted of immonium and related ions corresponding to residues L, I, Y, V, N,
D and F. (A) The base peak chromatogram during the LC-MS/MS procedure. (B) The total ion chromatogram (TIC) for the precursor ion scan
with target ion 86 m/z which corresponds to Ile and Leu. (C) The precursor scan at time point 50.6 min (which corresponds to the major peak in
the TIC) showing the presence of an intense peak for 651.5 m/z which corresponds to the insulin peptide FVNQHLCGSHLVEALYLVCGER. (D) The
mass spectrum at the 50.6 min time point showing that the 651.5 m/z ion is of low abundance relative to the complex spectral background. (E)
The Product ion spectrum for the ion at m/z 651.5 which was acquired due to detection of a target ion during the precursor scan at time point
50.6 min. The sequencing ions lead to a positive identification of the peptide FVNQHLCGSHLVEALYLVCGER. Both the LC-MS/MS and precursor
ion scan data sets were submitted to the same ProteinPilot version 4 search engine. Only the Precursor ion scan identified peptides liberated
from insulin.
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duct ion spectrum and an EMS. Figure 3 shows a total
ion chromatogram (TIC) for the precursor scan for m/z
86 (immonium ion corresponding to leucine/isoleucine)
and a major peak at time point 50.6 min. At this time
point the major precursor mass that was giving a signal
for the presence of an 86 m/z was 651.7 and accordingly
an IDA-triggered EPI was generated. The MS/MS data
in this spectrum corresponds to that of the insulin-
derived tryptic-like peptide FVNQHLCGSHLVEA-
LYLVCGER (Table 2). In addition to the EPI we
included an EMS to be triggered during the precursor
scan in order to provide context. Figure 3 (bottom right
panel) shows the mass spectrum at the same time point
for when the 651 m/z peptide was identified (50.6 min).
H e r ew es e et h a tt h ep e p t i d ew o u l dn o th a v eb e e n
observed during a conventional MS/MS acquisition due
to the large number of ions with much greater ion
intensity than the insulin peptide signal. These data
shows that despite the target peptide being in low abun-
dance relative to the complex spectral background it
still gives the highest intensity signal during the precur-
sor scan, resulting in “targeted data acquisition” for a
peptide that was derived from insulin regardless of
matrix complexity. When the data acquired was sub-
jected to analysis by ProteinPilot version 4 the only suc-
cessful protein ID was insulin.
Summary
We have shown that by using stable isotope labeled
matrices combined with precursor ion scanning and
monitoring low mass ions, we are able to selectively
screen for peptides liberated from proteins of interest.
The precursor scanning technique assumes no prior
knowledge or prediction of how the products within
that matrix will form and is able to specifically screen
peptides that may even contain unanticipated post
translational modifications. The selectivity employed in
triple quadrupole technology allows for targeted frag-
mentation data acquisition for the peptides/metabolites
of interest at low abundance relative to a complex endo-
genous background. Furthermore, the data acquired is
readily searchable using current informatics algorithms
without a requirement to analyze MS/MS data contain-
ing
15N or alternative stable isotopes. This technique
will find many applications in monitoring changes to
biomolecules - especially in relation to biotherapeutics -
within complex sample mixtures. Moreover, with the
advent of isotopically labeled animal feed one can envi-
sion the use of this technique for absorption, distribu-
tion, metabolism, and excretion (ADME) type studies of
peptide and protein drugs in experimental animals.
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